Federal Immunity Agreements Use Immunity Vs Transactional Immunity

In my 25 years as a federal prosecutor, I sat across the table from countless witnesses and targets who believed that an immunity agreement was a golden ticket — a complete shield against any and all criminal exposure. I can tell you without hesitation that this assumption is not just wrong; it is dangerously wrong, and I have watched it unravel lives and liberty in real time. The federal immunity landscape is governed by a specific statutory scheme codified at 18 U.S.C. §§ 6001 through 6005, and every single word in those provisions carries weight that most defendants and even some attorneys fail to fully appreciate. When I now represent clients as a federal criminal defense attorney, I make certain they understand precisely what they are giving up and what they are getting — because the gap between use immunity and transactional immunity is the gap between a conditional reprieve and an absolute pardon. That distinction can mean the difference between walking free and facing decades in a federal penitentiary.

The Two Immunity Buckets: How 18 U.S.C. § 6002 Draws a Line Most Defendants Miss

Federal immunity in the modern era is governed principally by 18 U.S.C. § 6002, a statute that Congress enacted as part of the Organized Crime Control Act of 1970 to replace the older transactional immunity framework with what we now call use and derivative-use immunity. When a federal prosecutor invokes this statute — and I personally invoked it dozens of times during my career — the witness receives protection that prohibits the government from using the compelled testimony, or any information directly or indirectly derived from that testimony, in a subsequent criminal prosecution. This sounds comprehensive on its face, and for good reason the Supreme Court in Kastigar v. United States held that it satisfies the Fifth Amendment's command that no person shall be compelled to be a witness against himself. But here is the catch that I have seen too many clients overlook: the government retains the right to prosecute you for the very crimes you described under oath if it can demonstrate by a preponderance of the evidence that its prosecution is based on evidence wholly independent of your immunized statements.

The phrase "wholly independent" does a tremendous amount of work in federal immunity litigation, and I have both built and attacked these evidentiary showings from every conceivable angle. What this means in practice is that if the FBI had gathered documents, surveillance footage, witness interviews, or physical evidence before you ever sat down for that proffer session or grand jury appearance, the Department of Justice can still indict you and use all of that pre-existing evidence against you. I have seen prosecutors meticulously wall off immunized testimony by assembling what we call a "Kastigar hearing" binder — a sealed evidentiary submission that maps out every piece of evidence the government intends to use and traces its origin to sources untouched by the compelled statement. The burden then shifts to the government to prove that its evidence is untainted, and while that burden is meaningful, it is far from insurmountable for a well-prepared prosecution team that documented its investigative steps before immunity was even on the table.

Transactional immunity, by contrast, is the nuclear option of witness protections — it bars any prosecution whatsoever for any offense related to the transaction, matter, or subject about which the witness testified. This is the kind of immunity that existed under the old federal statute, 18 U.S.C. § 2514 (repealed), and it is the kind that most people imagine when they hear the word "immunity" in a legal context. Under transactional immunity, if you testify about your role in a drug trafficking conspiracy, you cannot be prosecuted for that conspiracy, for substantive drug offenses arising from it, or for related crimes like money laundering that stem from the same underlying conduct. The protection is absolute and categorical, and it does not depend on the government's ability to segregate evidence or prove independent sources. But — and this is a critical but that I emphasize to every single client — Congress deliberately killed federal transactional immunity more than fifty years ago because it was viewed as too generous, too prone to abuse, and an unnecessary windfall that went beyond what the Fifth Amendment actually demands.

The practical consequence of this statutory choice is that when you receive a federal immunity order under 18 U.S.C. § 6002, you are receiving use immunity, not transactional immunity, unless some extraordinarily rare exception applies. I have encountered exactly zero instances in my career where a federal prosecutor voluntarily offered transactional immunity; the Department of Justice's internal policies, codified in the United States Attorneys' Manual (now the Justice Manual) at § 9-23.000, explicitly restrict prosecutors to seeking the least expansive immunity necessary to secure compelled testimony. The federal system has made a deliberate policy judgment that use immunity strikes the proper balance between the government's need for information and the witness's constitutional rights, and as a defense attorney I must now operate within that reality — which means I must counsel clients about the residual risks that survive even a properly executed immunity agreement.

When Kastigar Becomes a Trapdoor: The Perjury, Obstruction, and Breach Exceptions That Nullify Your Protection

One of the most sobering conversations I have with clients who are considering an immunity agreement is the discussion about what immunity does not cover, and this is where I draw directly on my experience on the other side of the table to explain the landscape with brutal candor. The protections of 18 U.S.C. § 6002 do not extend to prosecution for perjury under 18 U.S.C. § 1623, for making false statements under 18 U.S.C. § 1001, for obstruction of justice under 18 U.S.C. § 1503, or for contempt of court if you refuse to testify after immunity has been conferred. I have personally prosecuted individuals who walked into a grand jury believing their immunity agreement insulated them from all consequences, only to discover that a single false statement — even an immaterial one — could serve as the basis for a perjury indictment that carries a statutory maximum of five years in federal prison. The government's logic here is straightforward and has been consistently upheld by the courts: immunity is a tool to secure truthful testimony, not a license to lie under oath, and the statute's protections were never intended to immunize the act of lying to the tribunal that compelled your appearance.

I recall a case from my prosecutorial years in which a mid-level drug organization member received use immunity and testified extensively about his co-conspirators' activities, believing he had outsmarted the system and secured a complete pass. What he failed to appreciate was that the FBI had already executed search warrants on multiple locations, seized ledgers and communications, and debriefed cooperating witnesses who had no connection to his immunized statement. When his testimony conflicted with the documentary evidence and those independent witness accounts, the case agents brought the discrepancies to my attention, and we opened a perjury investigation that ultimately resulted in a conviction under § 1623. The irony was palpable: he walked into the grand jury facing potential drug conspiracy charges with a ten-year mandatory minimum, received immunity that protected him from that specific prosecution, and then earned himself a five-year perjury sentence because he could not resist the temptation to minimize his own role. The immunity agreement did not fail him; his failure to understand its boundaries is what destroyed him.

Beyond the perjury trap, there is another exception that does not receive nearly enough attention in defense circles: the breach of an immunity agreement's internal conditions. Many federal immunity arrangements are not pure statutory orders issued under 18 U.S.C. § 6003 but are instead contractual "letter agreements" negotiated between defense counsel and the United States Attorney's Office pursuant to informal proffer procedures. These agreements typically require the witness to provide complete and truthful cooperation, to testify consistently at all proceedings, and to refrain from committing additional crimes during the period of cooperation. If the government determines — and the standard for this determination is often left to the government's "sole discretion" under the language of the agreement — that the witness has breached any of these conditions, the immunity protections can be voided retroactively, and the witness's own proffer statements can be used against them in a subsequent prosecution. I have negotiated these agreements from both sides, and I can attest that the government drafts them with an asymmetry of power that is breathtaking in its scope and devastating in its consequences for the unprepared defendant.

Transactional Immunity's Vanishing Act: Why Congress Killed It and Where It Still Survives

The legislative history behind the shift from transactional immunity to use immunity is essential context for anyone navigating the federal criminal justice system, and it reflects a fundamental philosophical debate about the scope of the Fifth Amendment that the Supreme Court definitively resolved in 1972. Before 1970, federal immunity statutes — including the since-repealed 18 U.S.C. § 2514 — uniformly provided transactional immunity, meaning that a witness who was compelled to testify received complete protection from prosecution for any matter related to the compelled testimony. This approach was rooted in the 1892 decision in Counselman v. Hitchcock, 142 U.S. 547, where the Court suggested that nothing short of absolute immunity could supplant the Fifth Amendment privilege. But Congress, responding to the increasing sophistication of organized crime and the need to secure testimony from reluctant witnesses with inside knowledge, determined that transactional immunity was an impediment to effective law enforcement because it frequently required granting a broader pardon than the witness's constitutional rights demanded.

When the Organized Crime Control Act of 1970 replaced § 2514 with the current § 6002, the statute explicitly authorized only use and derivative-use immunity, setting up an immediate constitutional challenge that reached the Supreme Court in Kastigar v. United States. The petitioners in Kastigar argued that anything less than transactional immunity violated the Fifth Amendment's guarantee that no person shall be compelled to be a witness against himself. The Court disagreed, holding in a decisive opinion that use immunity is coextensive with the constitutional privilege because the privilege protects against compelled self-incrimination, not against prosecution itself — and a bar on the use of compelled testimony and its fruits fully eliminates the compulsion concern. I have read and reread Kastigar countless times over the decades, and its reasoning is both elegant and unsparing: the Fifth Amendment is not a general grant of amnesty, and Congress is not required to give witnesses more protection than the Constitution itself provides simply because an earlier, more generous statute once did so.

Despite its near-total disappearance from federal practice, transactional immunity has not vanished entirely from the American legal landscape, and I have encountered situations where its ghost still haunts the margins of federal prosecutions. Several states — including New York under its Criminal Procedure Law § 50.30 and Massachusetts under its state constitution as interpreted by the Supreme Judicial Court — continue to require transactional immunity as a matter of state constitutional law, meaning that state prosecutors in those jurisdictions must grant broader protection than their federal counterparts. Additionally, in the federal system, there remains a narrow statutory vestige of transactional immunity under the witness protection provisions of 18 U.S.C. § 3523, which authorizes the Attorney General to provide such protection in extraordinary circumstances involving witnesses whose safety is at grave risk. I have also seen transactional immunity arise in the context of international extradition, where a foreign sovereign may demand assurances of non-prosecution broader than use immunity as a condition of extradition under an applicable treaty, and these assurances, once given, bind the United States under international comity principles.

From the Prosecutor's Side of the Table: What I Assessed Before Handing Anyone an Immunity Letter

When I was a federal prosecutor evaluating whether to seek an immunity order under 18 U.S.C. § 6003 — a decision that requires personal approval from the United States Attorney and, in many districts, consultation with Main Justice in Washington — I applied a rigorous cost-benefit calculus that every defense attorney should understand because it reveals the government's strategic priorities and pressure points. The threshold question was always whether the witness's testimony was "necessary to the public interest," the statutory standard that governs immunity requests, and this inquiry involved weighing the seriousness of the offense under investigation against the culpability of the witness whose testimony we sought. I would not, and under DOJ policy could not, seek immunity for a high-level target who orchestrated the criminal enterprise if lower-level participants could provide substantially the same evidence without requiring the extensive procedural machinery of a § 6003 order. The internal approval process was deliberately burdensome precisely because Congress wanted to prevent prosecutors from handing out immunity like candy, and the documentation requirements — including detailed memoranda to the Criminal Division — served as a meaningful check on prosecutorial discretion.

The second factor I assessed, and one that defense counsel should probe aggressively during negotiations, was the evidentiary baseline the government had already assembled independent of the witness's anticipated testimony. In my prosecutorial days, before I ever picked up the phone to discuss immunity with defense counsel, I instructed case agents to prepare a comprehensive inventory of every piece of evidence we had gathered — search warrant returns, consensual recordings, physical surveillance logs, financial records, and statements from other cooperating witnesses. This inventory, often compiled in what we called a "time-stamped evidence chronology," became the foundation for any future Kastigar hearing and effectively defined the universe of provable charges that could survive an immunity challenge. The strategic implication for the defense is profound: a client who is approached about immunity should assume that the government has already built a substantial portion of its case through independent means, and that the immunity offer is not an act of prosecutorial desperation but rather a calculated decision to fill evidentiary gaps or secure a compelling witness for trial presentation.

I also evaluated what I call the "credibility vector" — a term I coined during my years as a prosecutor to describe the trajectory of a witness's perceived honesty and reliability as the investigation progressed. A witness who had given inconsistent statements during initial law enforcement interviews, who had a documented history of dishonesty, or who had motivations to shade the truth in favor of particular outcomes represented a significant liability even if immunized, because a perjury prosecution, while legally viable, is a poor substitute for the original charges you sacrificed. The credibility assessment also implicated the trial-team dynamics: an immunized witness who crumbles under cross-examination about the immunity agreement's existence — and every competent defense attorney will cross-examine vigorously on the benefits the witness received — can undermine an otherwise strong prosecution. These considerations meant that I frequently declined to seek immunity not because the witness lacked valuable information but because the witness lacked the fundamental credibility to carry that information across the finish line of a jury verdict, and this is an insight that defense counsel can exploit when arguing against the sufficiency or good faith of a government immunity overture.

Frequently Asked Questions

Can I be prosecuted for crimes I mention during immunized testimony if the government already had evidence of those crimes before I testified?

Yes, and this is the single most important limitation on use immunity under 18 U.S.C. § 6002. The government can prosecute you for any crime — including crimes you discussed in your compelled testimony — if it can demonstrate at a Kastigar hearing that its evidence comes from a source wholly independent of your immunized statements. Independent sources include evidence gathered through search warrants executed before your testimony, witness interviews conducted prior to your cooperation, physical evidence collected during the investigation, and any documentary or forensic evidence that was in the government's possession before immunity attached. The government bears the burden of proving by a preponderance of the evidence that each piece of evidence it intends to use is untainted, and this burden is typically satisfied through detailed affidavits from case agents and prosecutors describing the investigative timeline and the origin of each evidentiary item. In my experience, well-managed federal investigations maintain meticulous records precisely to satisfy this burden, and I have seen many defendants stunned to learn that their immunized admissions, while not directly usable against them, did nothing to dismantle the independent case the government had already constructed.

Is transactional immunity ever available in federal cases today?

For all practical purposes, transactional immunity is extinct in the federal criminal justice system, and I would caution any defendant or witness against assuming